Multiple criteria decision analyisis for health technology assessment: scientific substantiation of criteria selection in Ukraine
Journal Title: Фармацевтичний журнал - Year 2017, Vol 5, Issue 5
Abstract
Multiple-criteria decision analysis (MCDA) is a framework where multiple criteria are being considered in a well-structured manner during the decision-making process. This methodology is becoming increasingly popular for aiding and supporting health-care decision making. Defining the criteria is a critical stage in the process as it forms the foundation of MCDA. Our aim was to review information sources on the application of MCDA in practice in the world and to analyze the criteria included in the MCDA models. Research objects were MCDA reports and models from PubMed database. Research methods were system and content analyzes, data synthesis, generalization, extrapolation, statistical. We reviewed scientific publications and official documents of existing or proposed MCDA models. We identified the criteria and assigned them into nine groups: Economics, Disease description, Intervention description, Health gain, Feasibility, Prevalence, Evidence quality, Social and ethical factors and Other criteria. We looked at MCDAs which are aimed to be used for Reimbursement or Investment Decisions (86%) and for Authorization Decisions (14%). Of the reviewed 25 MCDA models aimed to support reimbursement decisions only 1 lacks cost-related criteria, while 7 scoring systems lack social and ethical factors and 12 MCDAs don’t mention epidemiology or classification of target groups directly. We found that none of the reviewed MCDAs used for authorization decisions mentioned socioeconomic criteria. There is no direct connection between the number of criteria included in MCDA models intended to support reimbursement decisions and the GDP per capita figures of countries. It can be seen that the selection of criteria has no standardized approach yet and most of the existing or proposed MCDA models were conducted to be relevant for decision-makers in the particular decision problems. The MCDAs supporting reimbursement decisions considered more criteria and the majority of them included economics and societal factors while most MCDAs intended to support authorization decisions only focused on the potential health benefits and outcomes. The most MCDA models included in our research were built in high-income countries.
Authors and Affiliations
O. B. Piniazhko, Olha Zaliska
Keywords
Related Articles
- EP ID EP556070
- DOI 10.32352/0367-3057.5-6.17.03
- Views 71
- Downloads 0
Marketing analysis of the pharmaceutical market in Ukraine opioid analgesics
Opioid analgesics (OA) are essential medicines, in particularly for pain relief in palliative care. At the same time the problem of availability of this medicines for medical need is common in many countries. Among the c...
Experimental study of antimicrobial activity of gel based on PHDP and its combinations with azelaic acid and benzoyl peroxide
The creation of combined medicines for the treatment of dermatological diseases based on the substances of natural origin, in particular phenol-hydrophobic drug propolis with reduced content of benzoyl peroxide and azela...
Justification of local anesthetic and choice of its concentration in composition of dental gel
Dental diseases are often accompanied by painful sensations, so usually symptomatic treatment of these pathologies includes local anesthetics, as which we have selected anesthetic of local action – lidocaine hydrochlorid...
Research of acute toxicity of the drug HEXIA
Diseases of the genitourinary system caused by pathogenic and potentially pathogenic microorganisms, which result into disbiosis of urinary organs, remain an urgent problem of dermatovenereology, gynecology and urology,...
Research of influence of pharmaceutical factors on the process of creation of pills with the operating substance of a 1 class of BSС on the example of bisoprolol fumarate
Among the diseases of population of Ukraine and world the first place is occupied by the diseases of the cardiovascular system. The evidential base of efficiency of application of b-blockers at the different forms of isc...